Ancora Advisors’s Invacare Corporation IVC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-21,750
| Closed | -$370 | – | 2006 |
|
|
2023
Q1 | $370 | Sell |
21,750
-500
| -2% | -$293 | ﹤0.01% | 1765 |
|
|
2022
Q4 | $9K | Hold |
22,250
| – | – | ﹤0.01% | 1378 |
|
|
2022
Q3 | $17K | Buy |
22,250
+4,000
| +22% | +$4.21K | ﹤0.01% | 1388 |
|
|
2022
Q2 | $23K | Buy |
18,250
+16,750
| +1,117% | +$22.1K | ﹤0.01% | 1402 |
|
|
2022
Q1 | $2K | Sell |
1,500
-45,523
| -97% | -$97.4K | ﹤0.01% | 2201 |
|
|
2021
Q4 | $128K | Hold |
47,023
| – | – | ﹤0.01% | 950 |
|
|
2021
Q3 | $224K | Buy |
47,023
+13,500
| +40% | +$98.6K | 0.01% | 760 |
|
|
2021
Q2 | $270K | Sell |
33,523
-1,920
| -5% | -$16K | 0.01% | 692 |
|
|
2021
Q1 | $284K | Sell |
35,443
-14,889
| -30% | -$139K | 0.01% | 646 |
|
|
2020
Q4 | $450K | Sell |
50,332
-2,950
| -6% | -$24.5K | 0.01% | 484 |
|
|
2020
Q3 | $401K | Sell |
53,282
-12,748
| -19% | -$88.4K | 0.02% | 477 |
|
|
2020
Q2 | $421K | Sell |
66,030
-4,012
| -6% | -$26.8K | 0.02% | 457 |
|
|
2020
Q1 | $521K | Sell |
70,042
-14,150
| -17% | -$110K | 0.02% | 455 |
|
|
2019
Q4 | $760K | Sell |
84,192
-21,811
| -21% | -$183K | 0.03% | 426 |
|
|
2019
Q3 | $795K | Buy |
106,003
+428
| +0.4% | +$2.4K | 0.03% | 366 |
|
|
2019
Q2 | $548K | Sell |
105,575
-20,834
| -16% | -$136K | 0.02% | 408 |
|
|
2019
Q1 | $1.06M | Sell |
126,409
-2,934
| -2% | -$21.1K | 0.05% | 297 |
|
|
2018
Q4 | $556K | Buy |
129,343
+38,481
| +42% | +$340K | 0.03% | 394 |
|
|
2018
Q3 | $1.32M | Buy |
90,862
+327
| +0.4% | +$5.42K | 0.05% | 307 |
|
|
2018
Q2 | $1.68M | Hold |
90,535
| – | – | 0.07% | 247 |
|
|
2018
Q1 | $1.57M | Sell |
90,535
-19,836
| -18% | -$350K | 0.07% | 260 |
|
|
2017
Q4 | $1.86M | Buy |
110,371
+3,561
| +3% | +$57.9K | 0.1% | 217 |
|
|
2017
Q3 | $1.68M | Buy |
106,810
+2,840
| +3% | +$40.5K | 0.1% | 234 |
|
|
2017
Q2 | $1.37M | Buy |
103,970
+2,070
| +2% | +$27.2K | 0.09% | 254 |
|
|
2017
Q1 | $1.21M | Buy |
101,900
+4,500
| +5% | +$53.9K | 0.08% | 262 |
|
|
2016
Q4 | $1.27M | Sell |
97,400
-6,400
| -6% | -$73.7K | 0.09% | 248 |
|
|
2016
Q3 | $1.16M | Hold |
103,800
| – | – | 0.12% | 203 |
|
|
2016
Q2 | $1.26M | Buy |
103,800
+12,000
| +13% | +$141K | 0.15% | 184 |
|
|
2016
Q1 | $1.21M | Buy |
91,800
+20,600
| +29% | +$292K | 0.15% | 175 |
|
|
2015
Q4 | $1.24M | Sell |
71,200
-600
| -0.8% | -$10.8K | 0.16% | 165 |
|
|
2015
Q3 | $1.04M | Hold |
71,800
| – | – | 0.13% | 196 |
|
|
2015
Q2 | $1.55M | Buy |
+71,800
| New | +$1.52M | 0.18% | 156 |
|
|
2015
Q1 | – | Sell |
-72,820
| Closed | -$1.26M | – | 159 |
|
|
2014
Q4 | $1.22M | Sell |
72,820
-4,000
| -5% | -$60.7K | 0.15% | 180 |
|
|
2014
Q3 | $907K | Sell |
76,820
-8,000
| -9% | -$122K | 0.12% | 212 |
|
|
2014
Q2 | $1.56M | Buy |
84,820
+14,600
| +21% | +$248K | 0.2% | 135 |
|
|
2014
Q1 | $1.34M | Sell |
70,220
-2,800
| -4% | -$57.6K | 0.19% | 139 |
|
|
2013
Q4 | $1.7M | Sell |
73,020
-1,589
| -2% | -$32.9K | 0.26% | 114 |
|
|
2013
Q3 | $1.29M | Hold |
74,609
| – | – | 0.22% | 118 |
|
|
2013
Q2 | $1.07M | Buy |
+74,609
| New | +$1.03M | 0.18% | 142 |
|
Ancora Advisors's IVC Position: Q2 2023 in Review
Ancora Advisors sold out of Invacare Corporation (IVC) in Q2 2023, closing a stake of 21,750 shares — an estimated $370 sold.
Ancora Advisors first reported a position in IVC in Q2 2013 and held it in 39 quarters. The position peaked at $1.86M in Q4 2017. 1 fund tracked by Wall St. Rank holds IVC as of Q2 2023.
- Ancora Advisors reported no remaining Invacare Corporation position as of Q2 2023 after selling out during the quarter.
- Ancora Advisors sold 21,750 Invacare Corporation shares in Q2 2023, an estimated $370.
- Ancora Advisors first reported a position in Invacare Corporation in Q2 2013 and held it in 39 quarters.
- Ancora Advisors's Invacare Corporation position peaked at $1.86M in Q4 2017.
- 1 fund tracked by Wall St. Rank held Invacare Corporation as of Q2 2023.
Based on Ancora Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.